Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Head and Neck Neoplasms × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

Cisplatin 60 Cetuximab 51 Radiotherapy 34 pembrolizumab 26 Radiotherapy, Intensity-Modulated 23 Carboplatin 21 Docetaxel 19 Paclitaxel 18 Fluorouracil 17 Pemetrexed 9 Erlotinib Hydrochloride 9 Nivolumab 8 Gemcitabine 8 Radiation 7 Drug Therapy 7 Bevacizumab 7 durvalumab 6 Panitumumab 6 Everolimus 6 epacadostat 5 Surgical Procedures, Operative 5 Standard of Care 5 Lapatinib 5 Gefitinib 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Ipilimumab 4 Cyclophosphamide 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡